Onconetix, Inc. /
Proteomedix
Onconetix adds Proteomedix to its business through share exchange
What happened
Onconetix, Inc. completed its share exchange with Proteomedix AG on Dec. 15, 2023, making Proteomedix a wholly owned subsidiary. The Parent issued stock in exchange for all outstanding voting equity of Proteomedix.
Terms weren't disclosed.
The source
Everything on this page comes from the source below.
Onconetix adds Proteomedix to its business through share exchange
This document is the source for the companies, stage and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Closed
The source this page is built from.
Source-verifiedPublished by the source
The source this page is built from.
Source-verified
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request an inviteAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly